Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Motor Activity × Tablets × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Motor Activity 1 Lymphoma 1 Leukemia 1 Insulin Resistance 1 Inflammation 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Brain Neoplasms 1

Interventions

Exercise 4 pembrolizumab 1 cemiplimab 1 beta-Glucans 1 avelumab 1 Tablets 1 Roflumilast 1 Nivolumab 1 Nadolol 1 Isoproterenol 1 Ipilimumab 1 Immune Checkpoint Inhibitors 1 Carvedilol 1 Bisoprolol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06643221 2024-10-16

Allo-X

University of Arizona

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡